Literature DB >> 11177401

Elevated lactate levels in hospitalized persons with HIV infection.

W Tantisiriwat1, P Tebas, L B Polish, E Casabar, W G Powderly, C J Fichtenbaum.   

Abstract

Lactic acidosis has been described in persons with HIV infection particularly in association with the use of nucleoside reverse transcriptase inhibitors (NRTIs). Little is known about the epidemiology of this problem. We reviewed the records of all HIV-infected adults with elevated lactate levels admitted to Barnes-Jewish hospital from 1996 to 1998. There were 37 patients identified with elevated lactate levels. The annual rate of elevated lactate levels was 22.6, 33.9, and 30.8 per 1,000 admissions in 1996, 1997, and 1998, respectively. The median age of the patients was 40.4 years; median CD4(+) count was 148 cells/mm(3); and the median HIV-1 RNA level was 4,401 copies/ml. The median lactate level was 4.5 mmol/liter (range, 2.2-19 mmol/liter). Twenty-nine patients (78%) had elevated lactate levels at admission. Elevated lactate levels were associated with sepsis (48.7%), pancreatitis (13.5%), liver failure (8.1%), multiorgan failure (8.1%), and other conditions. Five patients had lactic acidosis associated with the use of antiretroviral medications; one patient with unexplained lactic acidosis and four patients with pancreatitis. The mortality rate was 45.9% (17/37). Higher lactate levels were associated with increased mortality. In conclusion, elevated lactate levels were uncommon but not rare in hospitalized patients with HIV infection. Sepsis was the most commonly associated condition and antiretroviral medications were the second most frequently associated factor. There was no significant increase in the annual rate of lactic acidosis during this 3-year period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11177401     DOI: 10.1089/088922201750063106

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

Review 1.  Aging and HIV/AIDS: pathogenetic role of therapeutic side effects.

Authors:  Rebecca A Torres; William Lewis
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

Review 2.  HIV disease and advanced age: an increasing therapeutic challenge.

Authors:  Roberto Manfredi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Profile of presentation of HIV-positive patients to an emergency department in Johannesburg, South Africa.

Authors:  Abdullah E Laher; Willem D F Venter; Guy A Richards; Fathima Paruk
Journal:  South Afr J HIV Med       Date:  2021-01-29       Impact factor: 2.744

Review 4.  Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.

Authors:  Alexa Hollinger; Nadine Cueni; Martin Siegemund; Anne Leuppi-Taegtmeyer; Catia Marzolini; Michael Dickenmann; Emmanuelle Landmann; Manuel Battegay; Aurélien Emmanuel Martinez
Journal:  AIDS Res Ther       Date:  2021-09-04       Impact factor: 2.250

5.  Immunometabolic Reprogramming in Response to HIV Infection Is Not Fully Normalized by Suppressive Antiretroviral Therapy.

Authors:  Pragney Deme; Leah H Rubin; Danyang Yu; Yanxun Xu; Gertrude Nakigozi; Noeline Nakasujja; Aggrey Anok; Alice Kisakye; Thomas C Quinn; Steven J Reynolds; Richard Mayanja; James Batte; Maria J Wawer; Ned C Sacktor; Deanna Saylor; Norman J Haughey
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

6.  Adipose Tissue Lactate Clearance but Not Blood Lactate Clearance Is Associated with Clinical Outcome in Sepsis or Septic Shock during the Post-Resuscitation Period.

Authors:  Ioannis Ilias; Sofia Apollonatou; Dimitra-Argyro Vassiliadi; Nikitas Nikitas; Maria Theodorakopoulou; Argyris Diamantakis; Anastasia Kotanidou; Ioanna Dimopoulou
Journal:  Metabolites       Date:  2018-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.